DEFINITIVE PROXY STATEMENTS

Company

Tonix Pharmaceuticals Holding Corp.

Filed

September 23, 2024

Period of Report

October 30, 2024

Accession Number

0001999371-24-012276

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →